Loading…
Underlying
Underlying Price
$8.33
Type
Put
Strike
11.5
Expiration
Oct 30, 2026
DTE
10d
Moneyness
ITM
Intrinsic
$3.17
IBRX 11.5 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $2.67 | +0.00% | 7 | 6 |
| Oct 30, 2026 | 10d | $1.98 | +30.26% | 5 | 6 |
| Nov 6, 2026 | 17d | — | — | 0 | 0 |
| Nov 13, 2026 | 24d | $2.02 | -4.72% | 1 | 5 |
| Nov 27, 2026 | 38d | — | — | 0 | 0 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.